Initial Clinical Manifestations and Early Diagnosis of Basal Cell Skin Carcinoma
Abstract
Background/Aim: Basal cell carcinoma (BCC) is the most common cancer of the skin. It is believed that increased UV radiation from the sun accounts for almost 90 % of the risk of BCC. There is a growing trend in the incidence of BCC in a younger population. The aim of study was to analyse the initial clinical symptoms of BCC that may be important for the early detection of this skin tumour.
Method: The study was a prospective, multicentre study performed in the period from March 2017 to February 2022. A total of 69 respondents with BCC were analysed. Respondents applied for a targeted examination to examine a suspicious skin lesion (due to certain symptoms) or were diagnosed with BCC by accident, when examining other skin changes. Respondents were divided into 2 groups. The first, Group I (35 respondents), consisted of respondents with nodular BCC. The second, Group II (34 respondents), consisted of respondents with superficial spreading BCC. Initially, a careful history and data on the characteristics, shape and character of the tumour were taken from all respondents. Data on all (even the smallest) initial symptoms and relevant signs of evolution, as well as subjective problems related to the tumour were noted. All respondents underwent dermoscopy of suspected skin changes.
Results: A significant difference was found between the examined groups in the characteristics of bleeding, crust formation and tendency to injury in lesions, where they occur more often in patients with nodular BCC. Symptoms such as burning and flaking occurred significantly more often in patients with superficial spreading BCC (p < 0.01), as well as the diameter of lesions over 5 mm (p < 0.05).
Conclusion: Early clinical diagnosis of BCC is possible with a tumour diameter of only a few mm. The predominant initial (highly susceptible) symptoms of nodular BCC were initial bleeding and / or scab formation on the lesions, as well as propensity to injury. The superficial spreading form of BCC was often larger than 5 mm in diameter, with more frequent scaling of the lesion, as well as burning and stinging sensations in the tumour area. Itching was observed to be a very common previous occurrence in the BCC initial focus zone in subjects of both study groups. Dermsocopy is a highly reliable diagnostic method for early detection of BCC.
References
Bandić J. The reliability of dermoscopic pigmented skin lesions differentiation [dissertation]. Banja Luka: Faculty of Medicine, University of Banja Luka, 2017; p. 12-44.
Cameron MC, Lee E, Hibler BP, Barker CA, Mori S, Cordova M, et al. Basal cell carcinoma: Epidemiology, patophisiology, clinical and histological subtypes, and disease associations. J Am Acad Dermatol 2019;80(2):303-17.
Drucker AM, Adam GP, Rofeberg V, Gazula A, Smith B, Moustafa F, et al. Treatments of primary basal cell carcinoma of the skin: a systematic review and network meta-analysis. Ann Intern Med 2018 Oct 2;169(7):456-66.
Kamath P, Darwin E, Arora H, Nouri KA. Review on imiquimod therapy and discussion on optimal menagement of basal cell carcinomas. Clin Drug Investig 2018;38(10):833-99.
Martens MC, Seebode C, Lehmann J, Emmert S. Photocarcinogenesis and skin cancer prevention strategies: an update. Anticancer Res 2018;38(2):1153-8.
Clark CM, Furniss M, Mackay-Wiggan JM. Basal cell carcinoma: an evidence-based treatment update. Am J Clin Dermatol 2014;15(3):197-216.
Bath-Hextall F, Ozolins M, Armstrong SJ, Colver GB, Perkins W, Miller PS, et al; Surgery versus Imiquimod for Nodular Superficial basal cell carcinoma (SINS) study group. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial. Lancet Oncol 2014 Jan;15(1):96-105.
van Loo E, Mosterd K, Krekels GA, Roozeboom MH, Ostertag JU, Dirksen CD, et al. Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10 year follow-up. Eur J Cancer 2014 Nov;50(17):3011-20.
OchoM, Lee J, James CL, Marshman G. Huilgol SC. Scalp basal cell carcinoma: review of 2.202 cases. Dermatol Surg 2016;42:834-41.
Kossard S, Epstein EH, Cerio R, Yu LL, Weedon D. Basal cell carcinoma. In: LeBoit PE, Burg G, Weedon D, Sarasain A. (Eds): World Health Organization Classification of Tumours. Pathology and genetics of skin tumours. Lyon, France: IARC Press, 2006; pp. 13-19.
Youssef KK, Van Keymeulen A, Lapouge G, Beck B, Michaux C, Achouri Y, et al. Identification of the cell lineage at the origin of basal cell carcinoma. Nat Cell Biol 2010;12:299-305.
Crowson AN. Basal cell carcinoma: biology, morphology and clinical implications. Mod Pathol 2006 Feb;19 Suppl 2:S127-47.
Dandurand M, Petit T, Martel P, Guillot B; ANAES. Management of basal cell carcinoma in adults Clinical practice guidelines. Eur J Dermatol 2006 Jul Aug;16(4):394-401.
Khan L, Breen D, Zhang L, Balogh J, Czarnota G, Lee J, et al. Predictors of recurrence after radiotherapy for non-melanoma skin cancer. Curr Oncol 2014 Apr;21(2):e326-9.
Kadouch DJ, van Haersma de With A, Limpens J, van der Wal AC, Wolkerstorfer A, et al. Is a punch biopsy reliable in subtyping basal cell carcinoma? A systematic review. Br J Dermatol 2016 Aug;175(2):401-3.
Luz FB, Ferron C, Cardoso GP. Surgical treatment of basal cell carcinoma: an algoritam based on the literature. An Bras Dermat 2015;90(3):377-83.
Wozniak-Rito A, Zalaudek I, Rudnicka L. Dermoscopy of basal cell carcinoma. Clin Exp Dermatol 2018;43:241-7.
Sgouros D, Apalla Z, Ioannides D, Katoulis A, Rigopoulos D, Sotiriou E, et al. Dermoscopy of common inflammatory disorders. Dermatol Clin 2018;36(4):359-68.
Merkel EA, Amin SM, Lee CY, Rademaker AW, Yazdan P, Martini MC, et al. The utility of dermoscopy-guided histologic sectioning for the diagnosis of melanocystic lesions. A case control study. J Am Acad Dermatol 2016;74(6):1107-13.
Choo JY, Bae JM, Lee JH, Lee JY, Park YM. Blue-gray blotch: A helpful dermoscopic finding in optimal biopsy site selection for true vasculitis. J Am Acad Dermatol 2016;75(4):836-8.
Lallas A, Argenziano G, Kyrgidis A, Apalla Z, Moscarella E, Longo C, et al. Dermoscopy uncovers clinically undetectable pigmentation in basal cell carcinoma. Br J Dermatol 2014 Jan;170(1):192-5.
Lallas A, Moscarella E, Argenziano G, Longo C, Apalla Z, Ferrara G, et al. Dermoscopy of uncommon skin tumours. Australas J Dermatol 2014 Feb;55(1):53-62.
Fargnoli MC, Kostaki D, Piccioni A, Micantonio T, Peris K. Dermoscopy in the diagnosis and management of non-melanoma skin cancers. Eur J Dermatol 2012 Jul-Aug;22(4):456-63.
Sanchez-Martin J, Vazquez-Lopez F, Perez-Oliva N, Argenziano G. Dermoscopy of small basal cell carcinoma: study of 100 lesions 5 mm or less in diameter. Dermatol Surg 2012 Jun;38(6):947-50.
Kim DP, Kus KJB, Ruiz E. Basal cell carcinoma review. Hematol Oncol Clin North Am 2019 Feb;33(1):13-24.
Reiter O, Mimouni I, Gdalevich M, Marghoob AA, Levi A, Hodak E, et al. The diagnostic accuracy of dermoscopy for basal cell carcinoma: A sysematic review and meta-analysis. J Am Acad Dermatol 2019;80(5):1380-8.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).